These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 12830411

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C, Toye B.
    BMC Infect Dis; 2004 Sep 20; 4():36. PubMed ID: 15380025
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nalidixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella typhi isolated from blood.
    Zafar A, Ibrahim NG, Ahsan T, Abbas Z, Zaidi A, Hasan R.
    J Coll Physicians Surg Pak; 2005 Jul 20; 15(7):413-7. PubMed ID: 16197870
    [Abstract] [Full Text] [Related]

  • 5. Low-level quinolone-resistance in multi-drug resistant typhoid.
    Mirza SH, Khan MA.
    J Coll Physicians Surg Pak; 2008 Jan 20; 18(1):13-6. PubMed ID: 18452661
    [Abstract] [Full Text] [Related]

  • 6. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.
    Ray P, Sharma J, Marak RS, Garg RK.
    Indian J Med Res; 2006 Jul 20; 124(1):105-8. PubMed ID: 16926465
    [Abstract] [Full Text] [Related]

  • 7. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi.
    Kim DM, Neupane GP, Jang SJ, Kim SH, Lee BK.
    Int J Antimicrob Agents; 2010 Aug 20; 36(2):155-8. PubMed ID: 20478696
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
    Dimitrov T, Dashti AA, Albaksami O, Jadaon MM.
    J Clin Pathol; 2010 Jan 20; 63(1):83-7. PubMed ID: 19889623
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fluoroquinolone resistance in Salmonella Typhi.
    Cooke FJ, Wain J, Threlfall EJ.
    BMJ; 2006 Aug 12; 333(7563):353-4. PubMed ID: 16902221
    [No Abstract] [Full Text] [Related]

  • 18. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK, Nair S, Wain J.
    J Antimicrob Chemother; 2006 Oct 12; 58(4):733-40. PubMed ID: 16895934
    [Abstract] [Full Text] [Related]

  • 19. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
    Ciraj AM, Seema DS, Bhat GK, Shivananda PG.
    Indian J Pathol Microbiol; 2001 Oct 12; 44(4):407-8. PubMed ID: 12035350
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.